Whitehawk Therapeutics (WHWK) Total Non-Current Liabilities (2020 - 2025)

Whitehawk Therapeutics (WHWK) has 6 years of Total Non-Current Liabilities data on file, last reported at $14.5 million in Q4 2025.

• On a quarterly basis, Total Non-Current Liabilities fell 17.69% year-over-year to $14.5 million in Q4 2025; TTM through Dec 2025 was $14.5 million, a 17.69% decrease from a year earlier, with the FY2025 full-year figure at $14.5 million, down 17.69% from the prior year.
• Total Non-Current Liabilities for Q4 2025 stood at $14.5 million, up from $9.8 million in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for WHWK reached as high as $27.2 million in Q4 2023 and fell as low as $8.8 million in Q2 2025.
• Historically, Total Non-Current Liabilities has averaged $16.4 million across 5 years, with a median of $16.4 million in 2024.
• On a YoY basis, Total Non-Current Liabilities climbed as much as 17.69% in 2025 and fell as far as 40.08% in 2025.
• Year by year, Total Non-Current Liabilities stood at $21.5 million in 2021, then retreated by 7.94% to $19.8 million in 2022, then jumped by 37.54% to $27.2 million in 2023, then sank by 35.22% to $17.6 million in 2024, then dropped by 17.69% to $14.5 million in 2025.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $14.5 million in Q4 2025, $9.8 million in Q3 2025, and $8.8 million in Q2 2025.